TD Asset Management Inc Acquires 103,207 Shares of Tilray Inc (NASDAQ:TLRY)

TD Asset Management Inc grew its stake in shares of Tilray Inc (NASDAQ:TLRYFree Report) by 8.1% in the second quarter, according to its most recent filing with the SEC. The institutional investor owned 1,373,045 shares of the company’s stock after purchasing an additional 103,207 shares during the period. TD Asset Management Inc owned about 0.18% of Tilray worth $2,278,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also recently modified their holdings of TLRY. Tidal Investments LLC grew its stake in shares of Tilray by 36,687.0% in the 1st quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock worth $26,373,000 after acquiring an additional 10,648,403 shares in the last quarter. Vanguard Group Inc. raised its holdings in shares of Tilray by 3.5% in the 1st quarter. Vanguard Group Inc. now owns 3,525,160 shares of the company’s stock valued at $8,707,000 after acquiring an additional 117,891 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in Tilray by 8.7% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock worth $6,699,000 after acquiring an additional 213,834 shares in the last quarter. Swiss National Bank lifted its holdings in shares of Tilray by 3.6% in the 1st quarter. Swiss National Bank now owns 1,490,938 shares of the company’s stock worth $3,683,000 after acquiring an additional 51,700 shares during the last quarter. Finally, CIBC Asset Management Inc boosted its holdings in Tilray by 13.3% during the 2nd quarter. CIBC Asset Management Inc now owns 871,299 shares of the company’s stock valued at $1,445,000 after acquiring an additional 102,316 shares during the period. 9.35% of the stock is owned by hedge funds and other institutional investors.

Tilray Stock Down 1.2 %

Shares of NASDAQ TLRY opened at $1.70 on Friday. The company has a quick ratio of 1.42, a current ratio of 2.27 and a debt-to-equity ratio of 0.10. The firm’s fifty day moving average is $1.82 and its 200 day moving average is $1.87. The company has a market cap of $1.32 billion, a price-to-earnings ratio of -3.86 and a beta of 2.13. Tilray Inc has a 52 week low of $1.50 and a 52 week high of $3.22.

Tilray (NASDAQ:TLRYGet Free Report) last released its quarterly earnings results on Monday, July 29th. The company reported ($0.04) EPS for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Tilray had a negative net margin of 30.26% and a negative return on equity of 2.63%. The business had revenue of $229.90 million for the quarter, compared to the consensus estimate of $226.20 million. During the same period in the previous year, the company earned ($0.15) EPS. The company’s revenue for the quarter was up 24.8% on a year-over-year basis. On average, equities research analysts expect that Tilray Inc will post -0.12 earnings per share for the current year.

Tilray Profile

(Free Report)

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.

Further Reading

Want to see what other hedge funds are holding TLRY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tilray Inc (NASDAQ:TLRYFree Report).

Institutional Ownership by Quarter for Tilray (NASDAQ:TLRY)

Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.